MR. MOHAMMAD RIAZ MD
Prescription History 1619947421
Internal Medicine - Medical Oncology in Katy, TX
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MR. MOHAMMAD RIAZ MD, an active Medical Oncology specialist practicing in Katy, TX. Our medical registry currently tracks 20 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 407 documented patient claims. Among these therapy options, the most frequently utilized medication is Ondansetron Hcl, which accounts for 44 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other TX PrescribersVs. TX Avg |
|---|---|---|---|
| Ondansetron Hcl | 44 | $8.42▼ below TX avg | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 44 Medicare prescriptions for Ondansetron Hcl, about 1.5 times the volume of the typical Texas prescriber of this medication (30.1). Medicare paid an average of $8.42 per fill, versus $12.56 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 44.7 30-Day Fills standardized to 30-day supplies 999 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 44 | $14.42▼ below TX avg | ≈ Typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 44 Medicare prescriptions for Tamoxifen Citrate, about 1.2 times the volume of the typical Texas prescriber of this medication (37). Medicare paid an average of $14.42 per fill, versus $26.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 70 30-Day Fills standardized to 30-day supplies 2,100 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 34 | $14.82 | ≈ Typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 34 Medicare prescriptions for Prochlorperazine Maleate, about 1.2 times the volume of the typical Texas prescriber of this medication (29.2). Medicare paid an average of $14.82 per fill, versus $14.01 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 739 Days of Medication total across all patients in 2024 | |||
| Warfarin Sodium | 25 | $0.71▼ below TX avg | ▼ Less than typical |
About Warfarin Sodium: This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Show more ▾ Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a "blood thinner," but the more correct term is "anticoagulant." It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. In 2024, this provider wrote 25 Medicare prescriptions for Warfarin Sodium, about 74% of the volume of the typical Texas prescriber of this medication (34). Medicare paid an average of $0.71 per fill, versus $8.54 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2024 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $21.78▼ below TX avg | ▼ Less than typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2024, this provider wrote 25 Medicare prescriptions for Hydrocodone-Acetaminophen, about a quarter of the volume of the typical Texas prescriber of this medication (120.1). Medicare paid an average of $21.78 per fill, versus $25.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 25 30-Day Fills standardized to 30-day supplies 590 Days of Medication total across all patients in 2024 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 24 | $20.78 | ≈ Typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2024, this provider wrote 24 Medicare prescriptions for Lidocaine-Prilocaine, about the same volume as the typical Texas prescriber of this medication (24.3). Medicare paid an average of $20.78 per fill, versus $16.64 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 675 Days of Medication total across all patients in 2024 | |||
| Letrozole | 23 | $22.00 | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 23 Medicare prescriptions for Letrozole, about a third of the volume of the typical Texas prescriber of this medication (56.5). Medicare paid an average of $22.00 per fill, versus $20.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,023 Days of Medication total across all patients in 2024 | |||
| XareltoRivaroxaban | 22 | $655.69▼ below TX avg | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2024, this provider wrote 22 Medicare prescriptions for Xarelto, about half the volume of the typical Texas prescriber of this medication (45.2). Medicare paid an average of $655.69 per fill, versus $943.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 26 30-Day Fills standardized to 30-day supplies 771 Days of Medication total across all patients in 2024 | |||
| RevlimidLenalidomide | 20 | $21,107.83 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 20 Medicare prescriptions for Revlimid, about half the volume of the typical Texas prescriber of this medication (36.7). Medicare paid an average of $21,107.83 per fill, versus $17,008.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2024 | |||
| Everolimus | 16 | $3,706.36 | ≈ Typical |
About Everolimus: Everolimus is used to treat various types of cancer (such as kidney, breast, pancreas, lung, stomach/intestinal cancers). Show more ▾ Everolimus is also used in people with a certain genetic disorder (tuberous sclerosis complex) to treat certain types of benign tumors in the brain or kidney. It works by slowing or stopping the growth of cancer or tumor cells. A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT. In 2024, this provider wrote 16 Medicare prescriptions for Everolimus, about 88% of the volume of the typical Texas prescriber of this medication (18.3). Medicare paid an average of $3,706.36 per fill, versus $3,659.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 470 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 16 | $13.57▼ below TX avg | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 16 Medicare prescriptions for Hydroxyurea, about half the volume of the typical Texas prescriber of this medication (34.4). Medicare paid an average of $13.57 per fill, versus $24.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| InqoviDecitabine/Cedazuridine | 15 | $8,414.13 | ▼ Less than typical |
About Inqovi: This medication contains 2 ingredients: decitabine and cedazuridine. Show more ▾ It is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells. People with MDS may have problems such as infections, anemia, and easy bleeding/bruising. Decitabine is thought to work by helping your bone marrow make normal blood cells. Decitabine also slows or stops the growth of abnormal blood cells that grow too fast and do not work properly. Cedazuridine helps decitabine work better by helping to prevent its breakdown in your body. In 2024, this provider wrote 15 Medicare prescriptions for Inqovi, about 74% of the volume of the typical Texas prescriber of this medication (20.4). Medicare paid an average of $8,414.13 per fill, versus $7,560.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Megestrol Acetate | 15 | $98.44 | ▼ Less than typical |
About Megestrol Acetate: Megestrol is used to treat loss of appetite and weight loss in people with AIDS. Show more ▾ Improving your appetite and gaining weight may help you feel better and be more active. Megestrol is similar to a natural substance made by the body called progesterone. Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2024, this provider wrote 15 Medicare prescriptions for Megestrol Acetate, about 62% of the volume of the typical Texas prescriber of this medication (24.1). Medicare paid an average of $98.44 per fill, versus $58.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.4 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 14 | $18.92 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 14 Medicare prescriptions for Gabapentin, about 15% of the volume of the typical Texas prescriber of this medication (96.4). Medicare paid an average of $18.92 per fill, versus $15.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Morphine Sulfate | 13 | $31.66 | ▼ Less than typical |
About Morphine Sulfate: This medication is used to help relieve moderate to severe pain. Show more ▾ Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. In 2024, this provider wrote 13 Medicare prescriptions for Morphine Sulfate, about a third of the volume of the typical Texas prescriber of this medication (33.3). Medicare paid an average of $31.66 per fill, versus $28.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 319 Days of Medication total across all patients in 2024 | |||
| Morphine Sulfate ErMorphine Sulfate | 12 | $23.40▼ below TX avg | ▼ Less than typical |
About Morphine Sulfate Er: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (100 milligrams or more per tablet) should be used only if you have been regularly taking moderate to large amounts of opioid pain medications. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of morphine to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. In 2024, this provider wrote 12 Medicare prescriptions for Morphine Sulfate Er, about 20% of the volume of the typical Texas prescriber of this medication (61). Medicare paid an average of $23.40 per fill, versus $31.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Imatinib Mesylate | 12 | $72.44▼ below TX avg | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 12 Medicare prescriptions for Imatinib Mesylate, about half the volume of the typical Texas prescriber of this medication (22.1). Medicare paid an average of $72.44 per fill, versus $1,513.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Lenalidomide | 11 | $14,922.53 | ▼ Less than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 11 Medicare prescriptions for Lenalidomide, about a third of the volume of the typical Texas prescriber of this medication (30.1). Medicare paid an average of $14,922.53 per fill, versus $13,686.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 11 | $16,397.31 | ▼ Less than typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 11 Medicare prescriptions for Imbruvica, about half the volume of the typical Texas prescriber of this medication (25.4). Medicare paid an average of $16,397.31 per fill, versus $14,878.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2024 | |||
| AlecensaAlectinib Hcl | 11 | $21,458.13 | ≈ Typical |
About Alecensa: Alectinib is used to treat a certain type of lung cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Alectinib belongs to a class of drugs known as tyrosine kinase inhibitors. An ANAPLASTIC LYMPHOMA KINASE (Alk) inhibitor. In 2024, this provider wrote 11 Medicare prescriptions for Alecensa, about 78% of the volume of the typical Texas prescriber of this medication (14.1). Medicare paid an average of $21,458.13 per fill, versus $17,192.09 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MR. MOHAMMAD RIAZ MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Medical Oncology prescribing approach at this Katy, TX practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among TX prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
